Event Brief
Mar 20, 2026 at 6:03 AM ET
England to Review Alzheimer’s Drug Rejection
By The BriefBrief
England's drug price regulator will reconsider its decision on Alzheimer’s treatments after appeals from Eli Lilly and others.
WHO: England’s drug price regulator
WHAT: reconsider its decision on Alzheimer’s disease treatments
WHEN: Mar 19, 2026 at 8:01 PM ET
WHERE: England
WHY: following successful appeals by the companies
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21432 of 21432
Same format. Every time.
Continue reading — sign in or create a free account with
